Brenda L. Banwell

Publications

Submitted by admin on Wed, 08/01/2012 - 01:00

Lauren B. Krupp, M.D.

Daniela Pohl, MD

on behalf of the REPLAY Study Group

Subcutaneous interferon β-1a in paediatric patients with multiple sclerosis: regional outcomes in an international retrospective study (REPLAY)

28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); October 2012; Lyon, France

Submitted by admin on Tue, 12/06/2011 - 00:00

Tanuja Chitnis, MD

Silvia Tenenbaum, MD

Brenda L. Banwell

Lauren B. Krupp, M.D.

Marc Tardieu, MD, PhD

A Kornberg

A Ghezzi

for the International Pediatric Multiple Sclerosis Study Group.

Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis.

Multiple Sclerosis, 2012 January;18(1):116-27

Submitted by admin on Tue, 01/01/2008 - 00:00

Lauren B. Krupp, M.D.

Dorothy J. Becker MD

Hans-Michael Dosch MD, PhD

Wadsworth Pediatric Multiple Sclerosis Study Group.

Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.

Annals of Neurology 2008;63:98-111

Submitted by admin on Sat, 09/01/2007 - 01:00

Brenda L. Banwell

Lauren B. Krupp, M.D.

Clinical features and viral serologies in pediatric multiple sclerosis: results of a multinational study.

Lancet Neurology 2007;6(9):773-81

Submitted by admin on Tue, 04/17/2007 - 03:00

Bianca Weinstock-Guttman, MD

for the International Pediatric MS Study Group

MRI features of pediatric multiple sclerosis

NEUROLOGY 2007;68(Suppl 2):S46–S53

Submitted by admin on Tue, 04/17/2007 - 02:00

Jayne Ness

Dorothee Chabas MD, PhD

Sadovnick, PhD

Daniela Pohl, MD

Brenda L. Banwell

Bianca Weinstock-Guttman, MD

for the International Pediatric MS Study Group

Clinical features of children and adolescents with multiple sclerosis

NEUROLOGY 2007;68(Suppl 2):S37–S45

Submitted by admin on Tue, 04/17/2007 - 01:00

Lauren B. Krupp, M.D.

Brenda L. Banwell

Silvia Tenenbaum, MD

International Pediatric MS Study Group.

Consensus definitions proposed for pediatric multiple sclerosis and related disorders.

Neurology 2007;68:S7-S12.

Submitted by admin on Tue, 02/28/2006 - 14:47

Brenda L. Banwell

Anthony T. Reder

Lauren B. Krupp, M.D.

I. Antonijevic, MD, PhD

Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis: A Multicenter Study.

Neurology 2006;66:472-6

Imaged parent items

Parent items

Main menu

Brenda L. Banwell

Publications

Subcutaneous interferon β-1a in paediatric patients with multiple sclerosis: regional outcomes in an international retrospective study (REPLAY)

Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis.

Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.

Clinical features and viral serologies in pediatric multiple sclerosis: results of a multinational study.

MRI features of pediatric multiple sclerosis

Clinical features of children and adolescents with multiple sclerosis

Consensus definitions proposed for pediatric multiple sclerosis and related disorders.

Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis: A Multicenter Study.

Imaged parent items

Parent items

Search form

Main menu

You are here

Brenda L. Banwell

Publications